AU2021356560A1 - Type i crispr-associated transposase systems - Google Patents

Type i crispr-associated transposase systems Download PDF

Info

Publication number
AU2021356560A1
AU2021356560A1 AU2021356560A AU2021356560A AU2021356560A1 AU 2021356560 A1 AU2021356560 A1 AU 2021356560A1 AU 2021356560 A AU2021356560 A AU 2021356560A AU 2021356560 A AU2021356560 A AU 2021356560A AU 2021356560 A1 AU2021356560 A1 AU 2021356560A1
Authority
AU
Australia
Prior art keywords
cell
cas
sequence
composition
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021356560A
Other languages
English (en)
Inventor
Makoto Saito
Jonathan STRECKER
Feng Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Broad Institute Inc
Original Assignee
Massachusetts Institute of Technology
Broad Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology, Broad Institute Inc filed Critical Massachusetts Institute of Technology
Publication of AU2021356560A1 publication Critical patent/AU2021356560A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Automatic Cycles, And Cycles In General (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2021356560A 2020-10-08 2021-10-08 Type i crispr-associated transposase systems Abandoned AU2021356560A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063089220P 2020-10-08 2020-10-08
US63/089,220 2020-10-08
PCT/US2021/054190 WO2022076830A1 (en) 2020-10-08 2021-10-08 Type i crispr-associated transposase systems

Publications (1)

Publication Number Publication Date
AU2021356560A1 true AU2021356560A1 (en) 2023-06-08

Family

ID=81126112

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021356560A Abandoned AU2021356560A1 (en) 2020-10-08 2021-10-08 Type i crispr-associated transposase systems

Country Status (7)

Country Link
US (1) US20230383315A1 (https=)
EP (1) EP4204562A4 (https=)
JP (1) JP2023544822A (https=)
CN (1) CN116234918A (https=)
AU (1) AU2021356560A1 (https=)
CA (1) CA3194645A1 (https=)
WO (1) WO2022076830A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117363554B (zh) * 2023-12-08 2024-04-09 清华大学 一种工程改造的嗜盐微生物及其构建方法和应用
CN118909782B (zh) * 2024-10-10 2025-02-18 中国科学院烟台海岸带研究所 一种除异味净水藻及其净化应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3124110A1 (en) * 2018-12-17 2020-06-25 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof
CA3132197A1 (en) * 2019-03-07 2020-09-10 The Trustees Of Columbia University In The City Of New York Rna-guided dna integration using tn7-like transposons

Also Published As

Publication number Publication date
CA3194645A1 (en) 2022-04-14
EP4204562A1 (en) 2023-07-05
EP4204562A4 (en) 2024-11-06
JP2023544822A (ja) 2023-10-25
WO2022076830A1 (en) 2022-04-14
US20230383315A1 (en) 2023-11-30
CN116234918A (zh) 2023-06-06

Similar Documents

Publication Publication Date Title
EP4291202A1 (en) Nuclease-guided non-ltr retrotransposons and uses thereof
EP4061941A1 (en) Retrotransposons and use thereof
WO2021055874A1 (en) Novel type vi crispr enzymes and systems
AU2021364399A1 (en) Reprogrammable iscb nucleases and uses thereof
WO2022159892A1 (en) Reprogrammable tnpb polypeptides and use thereof
WO2020236967A1 (en) Random crispr-cas deletion mutant
WO2021097118A1 (en) Small type ii cas proteins and methods of use thereof
WO2021062410A2 (en) Programmable polynucleotide editors for enhanced homologous recombination
EP4051789A1 (en) Type i-b crispr-associated transposase systems
EP4271403A1 (en) Type i-b crispr-associated transposase systems
WO2021041922A1 (en) Crispr-associated mu transposase systems
EP4437094A1 (en) Reprogrammable iscb nucleases and uses thereof
WO2022150651A1 (en) Dna nuclease guided transposase compositions and methods of use thereof
WO2023230483A2 (en) Engineered chimeric iscb polypeptides and uses thereof
WO2023170535A2 (en) Novel nucleic acid-guided nucleases and use thereof
WO2024197008A2 (en) Nuclease-guided non-ltr retrotransposons and uses thereof
EP4204559A1 (en) Nucleic acid-guided nucleases and use thereof
CN116583599A (zh) 可重编程IscB核酸酶及其用途
AU2021356560A1 (en) Type i crispr-associated transposase systems
WO2024238835A2 (en) Novel crispr enzymes and systems
WO2024015920A1 (en) Hybrid crispr-cas systems and methods of use thereof
EP4436592A1 (en) Reprogrammable isrb nucleases and uses thereof
WO2024081711A2 (en) Reprogramable tnpb polypeptides and use thereof
WO2024081728A2 (en) Reprogrammable tnpb polypeptides with maze domains and uses thereof
WO2024211456A1 (en) Engineered type ii cas polynucleotides with reduced immunogenicity and uses thereof

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period